Those 60 wins in the regular season and that No. 1 seed don’t mean much for the Detroit Pistons right now. They’re one loss ...

Eli Lilly remains well-positioned in the obesity treatment market despite early script underperformance of Foundayo. Read ...

Eli Lilly (LLY) stock slips as IQVIA data show that the company's obesity drugs Zepbound and Foundayo lag Novo’s (NVO) Wegovy ...

Two early season traits — good and bad — had been established for the Royals entering Sunday: great starting pitching and trouble hitting with runners in scoring position. The Royals improved on the ...

Quantum computers struggle with a major flaw: their information vanishes unpredictably. Scientists have now created a new method that can measure this loss over 100 times faster than before. By ...

A new report dubbed "BrowserGate" warns that Microsoft's LinkedIn is using hidden JavaScript scripts on its website to scan visitors' browsers for installed extensions and collect device data.

Communities worldwide rely on reservoirs for drinking water, hydroelectric power, irrigation, and more. These critical freshwater resources are affected by seasonal and long-term changes; water levels ...

The Better Business Bureau is urging consumers to back up their digital data ahead of World Backup Day on March 31. Experts recommend the 3-2-1 rule: keep three copies of your data on two different ...

With the obesity numbers for Eli Lilly’s retatrutide already stacking up nicely, the company has rounded out its pitch for the triple agonist with top-line data on its ability to lower blood sugar ...

A new class of weight-loss drug just took a major step toward approval for use. In a phase 3 clinical trial, the medication retatrutide helped control blood sugar levels in participants with type 2 ...

North Carolina’s quarterfinal loss to Clemson played out as so many games have in the Hubert Davis era. The Tar Heels came out flat, played a lethargic 35 minutes and appeared on their way to another ...